Harold Mastalerz

Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers:  Inhibition of Aggregation by Methoxytriethyleneglycol Chains

Dalton King, Gene M. Dubowchik, Harold Mastalerz et al. · Journal of Medicinal Chemistry · 2002 · 134 citations

Peptide Engineering, Immunology, Molecular Biology +21

Discovery of a 2,4-Disubstituted Pyrrolo[1,2-<i>f</i>][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development

Mark D. Wittman, Joan M. Carboni, Yang Zheng et al. · Journal of Medicinal Chemistry · 2009 · 94 citations · Full text

Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling

Tai W. Wong, Francis Y. Lee, Chiang Yu et al. · Clinical Cancer Research · 2006 · 78 citations

An examination of O-2-isocephems as orally absorbable antibiotics

Harold Mastalerz, Marcel Ménard, Vivianne Vinet et al. · Journal of Medicinal Chemistry · 1988 · 48 citations

Analogous Cephems, Medicinal Chemistry, Pharmaceutical Science +14

The discovery of BMS-275183: an orally efficacious novel taxane

Harold Mastalerz, Donald J. Cook, Craig R. Fairchild et al. · Bioorganic & Medicinal Chemistry · 2003 · 47 citations

Biology, Natural Sciences, Molecular Biology +5